Genetic polymorphisms in the PACAP and PAC1 receptor genes and treatment response to venlafaxine XR in generalized anxiety disorder
暂无分享,去创建一个
[1] K. Rickels,et al. Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder , 2011, The Pharmacogenomics Journal.
[2] B. Bradley,et al. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor , 2011, Nature.
[3] J. Lönnqvist,et al. Circadian clock gene polymorphisms in alcohol use disorders and alcohol consumption. , 2010, Alcohol and alcoholism.
[4] M. Itokawa,et al. Replication study of association between ADCYAP1 gene polymorphisms and schizophrenia , 2010, Psychiatric genetics.
[5] J. Guelfi,et al. Desvenlafaxine for the Prevention of Relapse in Major Depressive Disorder: Results of a Randomized Trial , 2010, Journal of clinical psychopharmacology.
[6] D. Baldwin,et al. Escitalopram in the treatment of generalized anxiety disorder , 2005, Expert review of neurotherapeutics.
[7] J. Miyazaki,et al. Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP) , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] R. Maldonado,et al. Altered emotional behavior in PACAP-type-I-receptor-deficient mice. , 2001, Brain research. Molecular brain research.